ArticleFrontiers in oncology2021

Case Report: Long Progression-Free Survival of Immunotherapy for Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation.

Jianfeng Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.